Lyell Immunopharma, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2021 | $2.4M | $-55.4M | $-55.0M |
| Jun 2021 | $2.6M | $-62.7M | $-62.6M |
| Sep 2021 | $2.8M | $-49.2M | $-48.9M |
| Mar 2022 | $553.0K | $-68.6M | $-68.1M |
| Jun 2022 | $35.7M | $-37.3M | $-36.3M |
| Sep 2022 | $3.0K | $-66.4M | $-70.3M |
| Mar 2023 | $65.0K | $-62.6M | $-67.0M |
| Jun 2023 | $27.0K | $-65.9M | $-63.9M |
| Sep 2023 | $25.0K | $-59.0M | $-50.9M |
| Mar 2024 | $3.0K | $-55.6M | $-60.7M |
| Jun 2024 | $13.0K | $-51.5M | $-45.8M |
| Sep 2024 | $34.0K | $-50.5M | $-44.6M |
| Mar 2025 | $7.0K | $-57.4M | $-52.2M |
| Jun 2025 | $8.0K | $-47.1M | $-42.7M |
| Sep 2025 | $15.0K | $-37.3M | $-38.8M |
| Mar 2026 | $2.0K | $-44.3M | $-24.2M |
| Jun 2026 | $4.0K | $-47.3M | $-44.8M |